Blog / Archives
ASCO Update #2: Stock Performance Data as of 6/8/17
ASCO Update: Many Stocks Rallied on the News Over the Past Month ASCO Rally is Holding but Fails to Break Through to New 2017 Highs The stock performance of most companies with ASCO news is...
ASCO Update: Movers on the News-INCY PBYI RHHBY
June 5...ASCO Update: Incyte Puma and Roche A lot of the product news is already "baked into" stock prices but here is a brief summary of big movers today on clinical news updates. The bellwether...
Biotechs Sink Again in Sector Shift to Technology Stocks: Update-1
6/1/17 Update at close...Biotechs Bounce off Bottom of 3 Month Trading Range IBB up 1.8% back above $290 after hitting 200 SMA bottom. XBI up 2.7% to $69.54 at SMA 50. XBI 2017 top is $72. XLV a...
Biotech Fades After ASCO Abstract Rally
Biotech Fades with Profit Taking: Is the pre-ASCO Momentum Gone? Technicals Matter Drug Pricing Scrutiny Continues Biotechs faded today now that the rush of oncology drug news slowed down. NASDAQ...
ASCO Abstracts Week: Biotech Trends and Hot Stocks
Biotech Trends: Immuno-Oncology Stocks Trending Strong Await ASCO Meeting on June 2 Prices as of Monday 11:45A with NASDAQ up 0.73% FBT $106.75 up 0.2%, IBB flat at $290.64, XBI at $69.33 up 0.3%...
Biotechs Mired in a Trading Range: Breakout Delayed…Update-3
Update-3...ASCO Movers Today 5/18: IBB up 1.28% to $292.27, XBI up 2% to $70. Nice follow through in biotech after a nasty day on 5/17 attributed to ASCO and a move away from the "Trump Trade"...
Rayno Diagnostics and Tools: Hologic Beats Q1 Sales and EPS
Hologic, Inc. (HOLX) Beats: Revenues Increased 3.2% and GAAP diluted Earnings Increased 666.7% Compared to Prior Year Period (fiscal Q2) The base business grew 5.4% lead by molecular diagnostics,...
Large Cap Biopharmaceutical Valuations: Q1 2017
May 8, 2017 Large Cap Biopharma Valuations After Q1 Earnings Large cap biopharmaceutical stocks are about 3-4% off their 2017 highs but have been losing momentum. Here is a quick review of the...
Rayno Biobeat #3 2017 Biotech Breakout Coming-Update-2
Update: Big Down Day in Biotech XBI down 3% Article to follow: big movers down CELG,KITE, PBYI, TSRO, XLRN etc Update-1... 5/8/17...Biotech Sector Losing Momentum XBI down 4.3% over 5 days although...
Biotechs Running Again: Rayno Life Science Stocks-See Picks…Earnings Updates
Update #2 Large Cap Biopharmaceuticals: ABBV, ALXN, BMY, CELG Abbvie (ABBV) Reported Better than Expected Earnings and Revenues Worldwide GAAP revenues were $6.538B up 10.1% with Global Humira sales...